- Udyam number
- UDYAM-TS-09-0058063

Saanso Life Sciences Private Limited
About Saanso Life Sciences Private Limited
Data last updated:
Saanso Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 November 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2022PTC167988.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.53 Cr. It is led by directors Siva Bhaskara Paturi Naren and Vamse Krishna Ratnakaram.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.39 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹43.43 Lakh (net margin 2.5%) and EBITDA of ₹1.55 Cr (EBITDA margin 8.9%).
The company has about 114 employees on its provident fund (EPFO) records.
Saanso Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-09-0058063). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Saanso Life Sciences
Contact details
Saanso Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressModule A1 Sy. No 64/Part Quadrant 2, First Floor Cyber Towers, Hyderabad, Telangana, India – 500081
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Saanso Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Saanso Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Saanso Life Sciences Private Limited, buy the company report.
Financials of Saanso Life Sciences Private Limited
FY 2025 filings availableSaanso Life Sciences Private Limited reported revenue of ₹17.39 Cr (up 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 26% in the latest year. EBITDA rose 57% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.55 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹43.43 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 8.9% | ||
| Net Profit Margin | 2.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Saanso Life Sciences Private Limited, buy the company report.
Board of directors of Saanso Life Sciences Private Limited
Saanso Life Sciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siva Bhaskara Paturi Naren | Director | 03 Nov 2022 | 4 Years 0 Months | Current |
| Vamse Krishna Ratnakaram | Director | 30 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Saanso Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anshu Retail Private Limited | ₹17.4 Cr (FY 2024) | 10.0% | Bangalore, Karnataka, India | |||
| MTC Steel Alloys Private Limited | ₹17.4 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Sri Vigneshwara Petrochem Private Limited | ₹17.4 Cr (FY 2022) | 198.0% | Hyderabad, Telangana, India | |||
| Narain Papers Private Limited | ₹17.4 Cr (FY 2025) | -17.0% | Delhi, India | |||
| Corpus Lifescience Private Limited | ₹17.4 Cr (FY 2025) | 19.0% | Serampore, West Bengal, India | |||
| Saanso Life Sciences Private Limitedthis company | ₹17.39 Cr (FY 2025) | ₹43.43 Lakh | 2.5% | 26.0% | 114 | Hyderabad, Telangana, India |
| Parag Worldwide Private Limited | ₹17.39 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Labasia Bio-Medicals Private Limited | ₹17.39 Cr (FY 2024) | 9.0% | Sri Ganganagar, Rajasthan, India | |||
| Matri Shree Powertronics Private Limited | ₹17.39 Cr (FY 2024) | -8.0% | Varanasi, Uttar Pradesh, India | |||
| Sunon Modular India Private Limited | ₹17.38 Cr (FY 2025) | 82.0% | Hyderabad, Telangana, India | |||
| Pratapavat Private Limited | ₹17.38 Cr (FY 2025) | 4.0% | Delhi, India |
To see the full peer comparison of Saanso Life Sciences Private Limited, buy the company report.
Auditor
Saanso Life Sciences Private Limited is audited by GV & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GV & Co | FY 2023 | 012875S |
Shareholding
The shareholding of Saanso Life Sciences Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Saanso Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saanso Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saanso Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Saanso Life Sciences Private Limited has a workforce of 114 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
No GST registration is on our record for Saanso Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Saanso Life Sciences Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Yarramreddy Ramesh Reddy ceased to be Director on 01 Jan 2024.
Frequently asked questions
Saanso Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 November 2022 (4+ years old) and is registered under CIN U24299TG2022PTC167988.
Saanso Life Sciences has 2 current directors:
- Siva Bhaskara Paturi Naren - Director
- Vamse Krishna Ratnakaram - Director
The latest financial statements of Saanso Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Saanso Life Sciences is U24299TG2022PTC167988. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saanso Life Sciences was incorporated on 03 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Saanso Life Sciences by revenue are Anshu Retail Private Limited, MTC Steel Alloys Private Limited, Sri Vigneshwara Petrochem Private Limited, Narain Papers Private Limited, Corpus Lifescience Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Yarramreddy Ramesh Reddy ceased to be Director on 01 Jan 2024. Vamse Krishna Ratnakaram was appointed as Director on 30 Dec 2023. Siva Bhaskara Paturi Naren was appointed as Director on 03 Nov 2022.
Yes, Saanso Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-TS-09-0058063).
The registered office of Saanso Life Sciences is at Module A1 Sy. No 64Part Quadrant 2, First Floor Cyber Towers, Hyderabad, Telangana, India – 500081.
Saanso Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Saanso Life Sciences is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.

